The hTERT Promoter Enhances the Antitumor Activity of an Oncolytic Adenovirus under a Hypoxic Microenvironment

作者: Yuuri Hashimoto , Hiroshi Tazawa , Fuminori Teraishi , Toru Kojima , Yuichi Watanabe

DOI: 10.1371/JOURNAL.PONE.0039292

关键词: Telomerase reverse transcriptaseTumor microenvironmentOncolytic adenovirusTelomeraseHT29 CellsAdenoviridaeHypoxia (medical)Oncolytic virusBiologyMolecular biology

摘要: Hypoxia is a microenvironmental factor that contributes to the invasion, progression and metastasis of tumor cells. Hypoxic cells often show more resistance conventional chemoradiotherapy than normoxic cells, suggesting requirement novel antitumor therapies efficiently eliminate hypoxic We previously generated tumor-specific replication-competent oncolytic adenovirus (OBP-301: Telomelysin), in which human telomerase reverse transcriptase (hTERT) promoter drives viral E1 expression. Since activity hTERT gene has been shown be upregulated by hypoxia, we hypothesized that, under conditions, effect OBP-301 with would efficient wild-type 5 (Ad5). In this study, investigated effects Ad5 against cancer (20% oxygen) or (1% condition. condition induced nuclear accumulation hypoxia-inducible factor-1α upregulation The cytopathic was significantly higher Consistent their activity, replication OBP-301-mediated E1A expressed within areas xenograft tumors mice. These results suggest mediated through hypoxia-mediated activation promoter. Regulation adenoviruses promising strategy, not only for induction oncolysis, but also elimination

参考文章(47)
Eiso Hiyama, Keiko Hiyama, Telomere and Telomerase for the Regulation of Stem Cells Regulatory Networks in Stem Cells. pp. 123- 134 ,(2009) , 10.1007/978-1-60327-227-8_11
David Kirn, Robert L. Martuza, James Zwiebel, Replication-selective virotherapy for cancer: Biological principles, risk management and future directions Nature Medicine. ,vol. 7, pp. 781- 787 ,(2001) , 10.1038/89901
Shinae Kizaka-Kondoh, Hideko Konse-Nagasawa, Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia Cancer Science. ,vol. 100, pp. 1366- 1373 ,(2009) , 10.1111/J.1349-7006.2009.01195.X
Jessica A. Bertout, Shetal A. Patel, M. Celeste Simon, The impact of O2 availability on human cancer Nature Reviews Cancer. ,vol. 8, pp. 967- 975 ,(2008) , 10.1038/NRC2540
Ruben Hernandez-Alcoceba, Michael Pihalja, Dalong Qian, Michael F. Clarke, New Oncolytic Adenoviruses with Hypoxia- and Estrogen Receptor-Regulated Replication Human Gene Therapy. ,vol. 13, pp. 1737- 1750 ,(2002) , 10.1089/104303402760293574
Brian Keith, M. Celeste Simon, Hypoxia-inducible factors, stem cells, and cancer. Cell. ,vol. 129, pp. 465- 472 ,(2007) , 10.1016/J.CELL.2007.04.019
C J Anderson, S F Hoare, M Ashcroft, A E Bilsland, W N Keith, Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms. Oncogene. ,vol. 25, pp. 61- 69 ,(2006) , 10.1038/SJ.ONC.1209011
Minna Eriksson, Kilian Guse, Gerd Bauerschmitz, Pekka Virkkunen, Maija Tarkkanen, Minna Tanner, Tanja Hakkarainen, Anna Kanerva, Renee A Desmond, Sari Pesonen, Akseli Hemminki, Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells. Molecular Therapy. ,vol. 15, pp. 2088- 2093 ,(2007) , 10.1038/SJ.MT.6300300
Xiaochun Zhang, Ritsuko Komaki, Li Wang, Bingliang Fang, Joe Y. Chang, Treatment of Radioresistant Stem-Like Esophageal Cancer Cells by an Apoptotic Gene-Armed, Telomerase-Specific Oncolytic Adenovirus Clinical Cancer Research. ,vol. 14, pp. 2813- 2823 ,(2008) , 10.1158/1078-0432.CCR-07-1528
Jun-ichi Nakayama, Hidetoshi Tahara, Eiji Tahara, Motoki Saito, Kaori Ito, Hideo Nakamura, Toshio Nakanishi, Eiichi Nakanishi, Toshinori Ide, Fuyuki Ishikawa, Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nature Genetics. ,vol. 18, pp. 65- 68 ,(1998) , 10.1038/NG0198-65